SOFINNOVA INVESTMENTS, INC.
SOFINNOVA INVESTMENTS, INC. is a Pre-seed, Seed, Series A, Series B, Series C+ and ipo fund in the US and Global writing $10M–$50M checks into Healthcare and pharma.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+, ipo
- Sectors
- Healthcare, pharma
- Check size
- $10M–$50M
- Invests in
- US-wide, Global
- Actively investing
- Yes
- Founded
- 1976
- Assets under management
- $4.4B
Thesis
Sofinnova Investments is a venture capital firm established in 1976, specializing in life sciences, particularly therapeutic drug development. With approximately $4.4 billion in AUM, the firm operates globally from its headquarters in Menlo Park, CA, and offices in Boston and New York. Their investment strategy is therapeutic-agnostic and science-driven, focusing on companies addressing high unmet patient needs with clear clinical proof of concept and uniform patient populations. They invest across all stages, from pre-seed to IPO, with key sector focuses including oncology, respiratory, dermatology, ophthalmology, neurology, and women's health. Sofinnova provides hands-on support in drug development, regulatory navigation, and IPO preparation. Typical check sizes range from $10 million to $50 million.
Common questions
Does SOFINNOVA INVESTMENTS, INC. invest at the Pre-seed stage?
Yes. SOFINNOVA INVESTMENTS, INC. lists Pre-seed, Seed, Series A, Series B, Series C+ and ipo among the stages it invests in.
What check size does SOFINNOVA INVESTMENTS, INC. write?
SOFINNOVA INVESTMENTS, INC. writes $10M–$50M checks.
Where does SOFINNOVA INVESTMENTS, INC. invest?
SOFINNOVA INVESTMENTS, INC. invests in the US and Global.